UnitedHealth Group Options Signal Unusually High Volatility Ahead of Earnings Report

When it comes to costs, insuring shares of health insurers can sometimes be even more expensive than the health insurance policies they sell. UnitedHealth Group, which is scheduled to report its quarterly earnings on Tuesday, serves as a prime example of this unusual market dynamic.

Ahead of the earnings release, implied volatility is running at double the level of realized volatility. This means that the cost of options—essentially the price of insuring the underlying stock—is exceptionally high, creating an advantageous environment for strategies that sell option premiums.

For UnitedHealth shares, traders can leverage this premium environment by selling November options to significantly reduce the cost of longer-dated January calls by more than half. The company enters Tuesday’s report with much of the fallout from previous challenges already reflected in the stock price. Although rising healthcare costs continue to pose a headwind, management’s earnings per share (EPS) growth target of 13% to 16% remains achievable. Over the past five years, the stock has remained relatively flat.

Notably, 90% of UnitedHealth’s 52 million global customers reside within the United States, where the company covers approximately 12% to 13.5% of the total population.

Enrollment growth and underwriting margins are both critical drivers of earnings per share growth. In the managed care and health insurance sectors, underwriting margin represents the fundamental operational profitability generated from managing healthcare risk, measuring the return an insurer achieves from collecting premiums and managing medical expenses. On the enrollment front, Affordable Care Act (ACA) marketplace-driven enrollment is expected to decline, presenting a revenue headwind for a segment that has historically been a key growth driver. Fortunately, this segment represents a smaller portion of the overall enterprise compared to Medicare and Commercial lines. Commercial fee-based enrollment grew approximately 2.9% year-over-year between 2024 and 2025, while total Medicare enrollment grew by 4.5%. While the commercial growth rate may seem modest, United appears to be gaining market share, outpacing the roughly 1.4% growth in the overall U.S. workforce during the same period.

Stock Chart IconStock chart icon

UnitedHealth, 1 year

Trading at 17 times forward earnings, with free cash flow representing 5.7% of enterprise value and 6.5% of market capitalization, the stock is not pricing in a significant recovery. From an options perspective, the market is currently implying 40% volatility for a stock that has historically realized around 20%. This elevated expectation captures the uncertainty surrounding this week’s earnings, likely driven by several sharp, double-digit price swings following recent reports. For instance, the stock fell nearly 20% after the January release, followed by another significant decline in April 2025.

Currently, UNH sits approximately 12% to 13% below the midpoint of its two-year price range. The stock has declined in five out of its last eight earnings sessions. According to Cboe LiveVol data, current options pricing implies a potential 6.5% move following the upcoming report, which represents the second-highest expected volatility in nearly two years.

The trade?

Traders can execute a strategy to sell the November 340/420 strangle to help finance the purchase of the January 2027 400 call. Buying the January 400 call costs $18.20. Selling the November 420 call at $5.80 and the November 340 put at $4.80 generates a credit of $10.60, resulting in a net debit of approximately $7.60. This structure cuts the cost of the long call by roughly 58%. If UNH finishes November between 340 and 420, both short positions will expire worthless, leaving the trader with the January call for a net cost of $7.60 and a breakeven price of $407.60 at expiration. A rally above 420 is fully covered by the long 400 call. The primary risk lies to the downside: if the stock closes below 340 in November, the trader will be assigned the shares at 340, resulting in an effective entry basis of approximately $347.60, including the net debit.

• Buy 1 UNH Jan 2027 400 call $18.20 debit
• Sell 1 UNH Nov 420 call $5.80 credit
• Sell 1 UNH Nov 340 put $4.80 credit
• Net debit ~7.60 ($760 per spread, as each spread represents 100 shares)

Source link